KYMR vs TGTX
Kymera Therapeutics, Inc. · TG Therapeutics, Inc.
Relative return (rebased to 100)
Key stats
| Metric | KYMR | TGTX |
|---|---|---|
| Price | $118.15 | $53.93 |
| Market Cap | $9.82B | $8.26B |
| P/E | — | 18.46 |
| P/B | 6.51 | 13.67 |
| P/S | 250.55 | 13.39 |
| ROE | -20.6% | 74.0% |
| Net Margin | -794.0% | 72.6% |
| Gross Margin | — | — |
| Revenue Growth | -16.7% | 87.3% |
| Dividend Yield | — | — |
| EPS | -$3.74 | $2.92 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.